Holen Sie sich die Stockscreener-App
139.94
1.19%
-1.68
Handel nachbörslich:
140.00
0.06
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BIIB?
Forum
Prognose
Aktiensplit
Biogen Inc Aktie (BIIB) Neueste Nachrichten
Biogen Inc. $BIIB Stake Raised by B. Metzler seel. Sohn & Co. AG - MarketBeat
Biogen Shares Rally 1.43% on Key Therapeutic Advances and Strategic Expansion as $320M Volume Ranks 320th - AInvest
Biogen Showcases Lupus Pipeline But Investors Will Have To Wait For Data - insights.citeline.com
Western Digital, Adobe, Biogen See High Option Trading Volume - AInvest
Risk vs reward if holding onto Biogen Inc.2025 Analyst Calls & Reliable Trade Execution Plans - Newser
Stock Analysis | Biogen OutlookWeak Technicals Cloud Optimistic Fundamentals - AInvest
Investors Holding Back On Biogen Inc. (NASDAQ:BIIB) - 富途牛牛
Is it too late to sell Biogen Inc.Portfolio Gains Report & Daily Technical Forecast Reports - Newser
Biogen Thematic Pipeline Seminar: Lupus - MarketScreener
Should New Zorevunersen and LEQEMBI Launches Influence Biogen's (BIIB) Rare Disease Growth Strategy? - simplywall.st
Biogen Highlights Multiple Assets and Indications in Lupus - Biogen
Eisai and Biogen to launch new Alzheimer's treatment in the US - medwatch.com
Biogen, Eisai begin rolling FDA submissions for Leqembi injectable for starting dose - Seeking Alpha
These Stocks Are Moving the Most Today: Nvidia, Biogen, NIO, Spirit Aviation, and More - MSN
CW Advisors LLC Buys New Holdings in Biogen Inc. $BIIB - MarketBeat
Caisse DE Depot ET Placement DU Quebec Makes New Investment in Biogen Inc. $BIIB - MarketBeat
Ieq Capital LLC Grows Stock Position in Biogen Inc. $BIIB - MarketBeat
Is Biogen Inc. showing insider buying2025 Key Lessons & Smart Money Movement Alerts - khodrobank.com
Biogen Inc. $BIIB Stock Position Decreased by Canada Pension Plan Investment Board - MarketBeat
Can Biogen Inc. reach all time highs this year2025 Support & Resistance & Consistent Profit Trading Strategies - khodrobank.com
Will Biogen Inc. see short term momentumWeekly Volume Report & Free Reliable Trade Execution Plans - Newser
Biogen Inc. $BIIB Holdings Raised by Trexquant Investment LP - MarketBeat
Landscape Capital Management L.L.C. Takes $329,000 Position in Biogen Inc. $BIIB - MarketBeat
American Century Companies Inc. Cuts Stock Position in Biogen Inc. $BIIB - MarketBeat
BNP Paribas Financial Markets Has $50.11 Million Stock Holdings in Biogen Inc. $BIIB - MarketBeat
The Game-Changing Potential of LEQEMBI® IQLIK™ in Early Alzheimer's Disease Treatment and Its Impact on Biogen and Eisai’s Market Position - AInvest
Visual analytics tools that track Biogen Inc. performanceJuly 2025 Final Week & Verified Technical Signals - Newser
Biogen Participating in the Cantor Global Healthcare Conference - Biogen
Real time breakdown of Biogen Inc. stock performance2025 Big Picture & Technical Buy Zone Confirmation - Newser
Evaluating Biogen Inc. with trendline analysisPrice Action & Reliable Volume Spike Trade Alerts - Newser
How institutional ownership impacts Biogen Inc. stockWeekly Earnings Recap & Low Risk High Win Rate Stock Picks - Newser
Biogen to Participate in Upcoming Healthcare Conferences - Biogen
Biogen Executive Makes a Significant Stock Sale - TipRanks
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status - Quantisnow
Biogen's Stock Surges 5.60% on Bullish Candlestick Pattern and Elevated Volume Amid Overbought Technical Indicators - AInvest
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status - Placera.se
Eisai, Biogen begin FDA submission for Alzheimer’s autoinjector - Investing.com
First At-Home Injection Option for Alzheimer's: Eisai's LEQEMBI IQLIK Could Transform Treatment Access - Stock Titan
Biogen Jumps 5.6% on Heavy Volume as Technicals Signal Bullish Reversal - AInvest
Can Biogen Inc. sustain its profitabilityWeekly Stock Recap & Growth Oriented Trade Recommendations - خودرو بانک
Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch
Biogen’s Surging Stock: Is a Breakthrough Imminent? - StocksToTrade
Is Biogen Inc. stock undervalued right nowAnalyst Downgrade & Weekly Market Pulse Alerts - خودرو بانک
Biogen (BIIB) Stock Is Up, What You Need To Know - Yahoo Finance
Biogen’s Sudden Surge: A Strategic Insight? - timothysykes.com
Biogen’s Strategic Moves: New Horizons or Risk? - StocksToTrade
Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries - MSN
Sector Update: Health Care Stocks Retreat Tuesday Afternoon - MarketScreener
9.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):